2022
DOI: 10.1080/08982104.2022.2100902
|View full text |Cite|
|
Sign up to set email alerts
|

Spanlastics gel-A novel drug carrier for transdermal delivery of glimepiride

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 28 publications
2
1
0
Order By: Relevance
“…Increasing EA amount was reported to increase spanlastic bilayer membrane fluidity, and thereby, would promote higher drug release. Similar results were reported by Elsaied et al ( Elsaied et al, 2023 ) who highlighted the positive impact of increasing EA concentration on the in vitro release of the antidiabetic drug, glimepiride, from spanlastic vesicles.…”
Section: Resultssupporting
confidence: 90%
“…Increasing EA amount was reported to increase spanlastic bilayer membrane fluidity, and thereby, would promote higher drug release. Similar results were reported by Elsaied et al ( Elsaied et al, 2023 ) who highlighted the positive impact of increasing EA concentration on the in vitro release of the antidiabetic drug, glimepiride, from spanlastic vesicles.…”
Section: Resultssupporting
confidence: 90%
“…At lower ratios of Span® to EA (6:4, 1:1), PDI values were found to be lower, indicating the creation of small, evenly distributed vesicles. This was observed in samples F5, F6, and F11 ( Elsaied et al, 2022 ).…”
Section: Discussionsupporting
confidence: 53%
“…The EE percentages of Curcumin-loaded Spanlastic dispersions were significantly varied (F value = 428.86, P < 0.05) ranging from 99.788 % for F5 to 97.77 % for F12 as shown in Table 3 this may be due to the lipophilic nature of Curcumin that synergized the activity of Span 60® which promote the formation of stable vesicles in a highly effective entrapment (EE%) due to its lipophilic nature and saturated alkyl chains as reported in the article entitled “Spanlastic nanovesicles for enhanced ocular delivery of vanillic acid: design, in vitro characterization, and in vivo anti-inflammatory evaluation” ( Elsaied et al, 2022 ).…”
Section: Resultsmentioning
confidence: 95%